Jade Biosciences (JBIO) Shares Outstanding (2020 - 2026)

Jade Biosciences (JBIO) has 7 years of Shares Outstanding (Entity) data on file, last reported at $49.3 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 5858.92% year-over-year to $49.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.3 million (up 5858.92% YoY) and the FY2025 annual result came in at $31.4 million, up 3686.97% from the prior year.
• Shares Outstanding (Entity) rose to $49.3 million in Q1 2026, from $31.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $49.3 million in Q1 2026 to a low of $697405.0 in Q1 2022.
• A 5-year average of $9.2 million and a median of $797068.0 in 2024 frame the typical range for Shares Outstanding (Entity).
• The widest YoY moves for Shares Outstanding (Entity): up 9945.14% in 2022, down 0.39% in 2022.
• Tracing JBIO's Shares Outstanding (Entity) over 5 years: stood at $706335.0 in 2022, then gained by 12.3% to $793180.0 in 2023, then advanced by 4.4% to $828102.0 in 2024, then soared by 3686.97% to $31.4 million in 2025, then soared by 57.35% to $49.3 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $49.3 million (Q1 2026), $31.4 million (Q4 2025), and $32.6 million (Q3 2025), per Business Quant data.